Highly Accessed Viewpoint

Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term

Rachel C Jankowitz and Adam M Brufsky*

Breast Cancer Research 2012, 14:308 doi:10.1186/bcr3120

No comments have yet been made on this article.

Post a comment